Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
Dr. Martens plc (the "Company") announces that on 9 February 2021 the following directors / persons discharging managerial responsibility ('PDMRs') were granted Performance Share Awards (the "Awards") under the Company's Long Term Incentive Plan (the "LTIP") over ordinary shares of the Company (the "Shares").
| PDMR | Number of Shares |
| Kenny Wilson | 567,567 |
| Jon Mortimore | 364,864 |
As previously disclosed in the Company's final prospectus dated 29 January 2021, the Awards will vest subject to the achievement of challenging earnings per share (67% weighting) and relative total shareholder return (33% weighting) targets over three years and, on vesting, will be subject to a further two-year holding period.
No consideration was paid for the grant of the Awards and no price is payable on the exercise of the Awards.
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Kenny Wilson | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Executive Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Grant of performance share award under the Dr. Martens Long Term Incentive Plan | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
|
567,567 shares
£0 | ||||
| e) | Date of the transaction | 9 February 2021 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Jon Mortimore | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Financial Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Grant of performance share award under the Dr. Martens Long Term Incentive Plan | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
|
364,864 shares
£0
| ||||
| e) | Date of the transaction | 9 February 2021 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
